Need professional-grade analysis? Visit stockanalysis.com
$317.10B
41.54
5,304
0.99%
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR1998.00, up 1.16% from the previous close.
Over the past year, JBCHEPHARM has traded between a low of INR1651.10 and a high of INR2138.60. The stock has gained 18.2% over this period. It is currently 6.6% below its 52-week high.
JB Chemicals & Pharmaceuticals Limited has a market capitalization of $317.10B, with a price-to-earnings ratio of 41.54 and a dividend yield of 0.99%.
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.
Side-by-side comparison against top Healthcare peers.